https://www.selleckchem.com/products/sr-18292.html
67; 95% CI 0.62 to 0.72 for moderate-severe PTS and 0.70; 0.64 to 0.77 for severe PTS). An updated model with age as an additional variable performed similarly to the original model. CONCLUSION We externally validated the SOX-PTS score for estimating the risk of developing PTS, moderate to severe PTS, and severe PTS, in patients with proximal DVT. The score may be useful to predict PTS at the time of DVT diagnosis. Further external validation in different patient cohorts is required. This article is protected by copyright. All rights r
Aimer
Commentaire
Partagez
